Evaluating in vivo delivery of riboflavin with Coulomb- controlled iontophoresis for corneal collagen cross- linking: A pilot study

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 4, 2014, Pages 2731-2738

  Arboleda, Alejandro ^a,b   Kowalczuk, Laura ^c,d   Savoldelli, Michéle ^c,d   Klein, Christophe ^c,d   Ladraa, Sophia ^c,d   Naud, Marie Christine ^c,d   Aguilar, Mariela C ^a   Parel, Jean Marie ^a,b,e,f   Behar Cohen, Francine ^c,d,e  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b University of Miami College of Engineering   (United States)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e HÔTEL DIEU   (France)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Collagen cross linking; Drug delivery; Iontophoresis; Keratoconus; Riboflavin

Indexed keywords

DEXTRAN; EYEGATE; PHOSPHATE; PHOTOSENSITIZING AGENT; RIBOFLAVIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEAL COLLAGEN CROSS LINKING; COULOMB CONTROLLED IONTOPHORESIS; CROSS LINKING; DEBRIDEMENT; DRUG DIFFUSION; FLUOROMETRY; IONTOPHORESIS; NONHUMAN; PRIORITY JOURNAL; RAT;

COLLAGEN CROSS-LINKING; DRUG DELIVERY; IONTOPHORESIS; KERATOCONUS; RIBOFLAVIN;

ANIMALS; COLLAGEN; CORNEA; CROSS-LINKING REAGENTS; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; IONTOPHORESIS; KERATOCONUS; MICROSCOPY, CONFOCAL; PHOTOSENSITIZING AGENTS; PILOT PROJECTS; RATS; RATS, INBRED LEW; RIBOFLAVIN; TREATMENT OUTCOME;

EID: 84899701936     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-13931     Document Type: Article

References (29)

1. Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998;42:297-319.
2. Radner W, Zehetmayer M, Skorpik C, Mallinger R. Altered organization of collagen in the apex of keratoconus corneas. Ophthalmic Res. 1998;30:327-332.
3. Treatments. National Keratoconus Foundation. Available at: http://www.nkcf.org. Accessed March 20, 2013.
4. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-ainduced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135:620-627.
5. Wollensak G. Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol. 2006;17:356-360.
6. Wollensak G, Spoerl E, Wilsch M, Seiler T. Endothelial cell damage after riboflavin-ultraviolet-A treatment in the rabbit. J Cataract Refract Surg. 2003;29:1786-1790.
7. Gokhale N. Corneal endothelial damage after collagen crosslinking treatment. Cornea. 2011;30:1495-1498.
8. Fillippello M, Stagni E, O'Brart, D. Transepithelial corneal collagen crosslinking: bilateral study. J Cataract Refract Surg. 2012;38:283-291.
9. Mazzotta C, Balestrazzi A, Baiocchi S, Traversi C, Caporossi A. Stromal haze after combined riboflavin-UVA corneal collagen cross-linking in keratoconus: in vivo confocal microscopic evaluation [letter]. Clin Exp Ophthalmol. 2007;35:580-582.
10. Treatment Options for Keratoconus. The Keratoconus Center. Available at: http://www.keratoconus.com/10.html. Accessed March 20, 2013.
11. Behar-Cohen F, Milne P, Parel JM, Persaud I. Ocular iontophoresis. In: Edelhauser HF, Kompella UB, eds. Drug Product Development for the Back of the Eye (AAPS Advances in the Pharmaceutical Sciences Series 2). New York, NY: AAPS Press, Springer Publishing Co.; 2011:361-390.
12. Behar-Cohen F, Parel J-M, Pouliquen Y, et al. Iontophoresis of Dexamethasone in the treatment of endotoxin-induced-uveitis in rats. Exp Eye Res. 1997;65:533-545.
13. Halhal M, Renard G, Courtois Y, BenEzra D, Behar-Cohen F. Iontophoresis: from the lab to the bed side. Exp Eye Res. 2004; 78:751-757.
14. Yoo S, Dursun D, Dubovy S, et al. Iontophoresis for the treatment of Paecilomyces keratitis. Cornea. 2002;21:131-132.
15. Hayden BS, Jockovich ME, Murray TG, et al. Iontophoretic delivery of carboplatin in a murine model of retinoblastoma. Invest Ophthalmol Vis Sci. 2006;47:3717-3721.
16. Kralinger MT, Voigt M, Kieselbach GF, Hamasaki D, Hayden BC, Parel J-M. Ocular delivery of acetylsalicylic acid by repetitive coulomb controlled iontophoresis. Ophthalmic Res. 2003;35: 102-110.
17. Behar-Cohen F, Savoldelli M, Parel J-M, et al. Reduction of corneal edema in endotoxin-induced uveitis after application of l-name as nitric oxide synthase inhibitor in rats by iontophoresis. Invest Ophthalmol Vis Sci. 1998;39:897-904.
18. Berdugo M, Valamanesh F, Andrieu C, et al. Delivery of antisense oligonucleotide to the cornea by iontophoresis. Antisense Nucleic Acid Drug Dev. 2003;13:107-114.
19. Hattori M, Shimizu K, Katsumura K, et al. Effects of all-trans retinoic acid nanoparticles on corneal epithelial wound healing. Graefes Arch Clin Exp Ophthalmol. 2012;250:557-563.
20. Brzezińska E, Mielczarek C, Pajak W. Analysis of acid-base properties of riboflavin calculated via semi-empirical methods. Acta Pol Pharm. 2008;65:59-63.
21. Holopainen JM, Krootila K. Transient corneal thinning in eyes undergoing corneal cross-linking. Am J Ophthalmol. 2011; 152:533-536.
22. Bikbova G, Bikbov M. Transepithelial corneal collagen crosslinking by iontophoresis of riboflavin. Acta Ophthalmol. 2013; 92:e30-e34.
23. Malhotra C, Shetty R, Kumar RS, Veluri H, Nagaraj H, Shetty KB. In vivo imaging of riboflavin penetration during collagen cross-linking with hand-held spectral domain optical coherence tomography. J Refract Surg. 2012;28:776-780.
24. Vinciguerra P, Rechichi M, Rosetta P, et al. High fluence iontophoretic corneal collagen cross-linking: in vivo OCT imaging of riboflavin penetration. J Refract Surg. 2013;29: 376-377.
25. Mastropasqua L, Nubile M, Calienno R, et al. Corneal crosslinking: intrastromal riboflavin concentration in iontophoresisassisted imbibition versus traditional and transepithelial techniques. Am J Ophthalmol. 2014;157:623-630.
26. Baiocchi S, Mazzotta C, Cerretani D, Caporossi T, Caporossi A. Corneal crosslinking: riboflavin concentrations in corneal stroma exposed with and without epithelium. J Cataract Refract Surg. 2009;36:893-899.
27. Podskochy A. Protective role of corneal epithelium against ultraviolet radiation damage. Acta Ophthalmol Scand. 2004; 82:714-717.
28. Kolozsvári L, Nógrádi A, Hopp B, Bor Z. UV absorbance of the human cornea in the 240-to 400-nm range. Invest Ophthalmol Vis Sci. 2002;43:2165-2168.
29. Doutch JJ, Quantock AJ, Joyce NC, Meek KM. Ultraviolet light transmission through the human corneal stroma is reduced in the periphery. Biophys J. 2012;102:1258-1264.